Familial LCAT deficiency: from pathology to enzyme replacement therapy-Reference-Cited by-同舟云学术

Familial LCAT deficiency: from pathology to enzyme replacement therapy

Published:2015-10-01 Issue:5 Volume:10 Page:405-413
ISSN:1758-4299
Container-title:Clinical Lipidology
language:en
Short-container-title:Clinical Lipidology

Author:

Ossoli Alice¹,Lucca Fabio¹,Boscutti Giuliano²,Remaley Alan T³,Calabresi Laura¹

Affiliation:

1. Centro Grossi Paoletti, Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milan, Italy

2. Division of Nephrology, Azienda Ospedaliero-Universitaria Ospedali Riuniti di Trieste, Trieste, Italy

3. Lipoprotein Metabolism Section, Cardiovascular-Pulmonary Branch, National Heart, Lung, & Blood Institute, NIH, Bethesda, MD 20892, USA

Publisher

Informa UK Limited

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism

Link

https://www.tandfonline.com/doi/pdf/10.2217/clp.15.34

Reference48 articles.

1. Calabresi L, Simonelli S, Gomaraschi M, Franceschini G. Genetic lecithin:cholesterol acyltransferase deficiency and cardiovascular disease. Atherosclerosis 222, 299–306 (2012). • Comprehensive Review On Lecithin:Cholesterol Acyltransferase (Lcat) Deficiency.

2. Jonas A. Lecithin cholesterol acyltransferase. Biochim. Biophys. Acta 1529, 245–256 (2000).

3. Glukhova A, Hinkovska-Galcheva V, Kelly R et al. Structure and function of lysosomal phospholipase A2 and lecithin:cholesterol acyltransferase. Nat. Commun. 6, 6250 (2015).

4. Sensi C, Simonelli S, Zanotti I et al. Distant homology modeling of LCAT and its validation through in silico targeting and in vitro and in vivo assays. PLoS ONE 9, e95044 (2014).

5. Albers JJ, Utermann G. Genetic control of lecithin-cholesterol acyltransferase (LCAT): measurement of LCAT mass in a large kindred with LCAT deficiency. Am. J. Hum. Genet. 33, 702–708 (1981).

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Very low HDL levels: clinical assessment and management;Archives of Endocrinology and Metabolism;2023-01-18

2. A rare case of nephrotic syndrome and Tangier disease;CEN Case Reports;2022-12-10

3. Primär genetische Dyslipoproteinämien und Atheroskleroserisiko;Pädiatrische Fettstoffwechselstörungen und Atheroskleroserisiko – kompakt;2022

4. LCAT deficiency: a systematic review with the clinical and genetic description of Mexican kindred;Lipids in Health and Disease;2021-07-13

5. High-Density Lipoproteins and the Kidney;Cells;2021-03-31